European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria

G. Valentini, W. Bencivelli, S. Bombardieri, S. D'Angelo, A. Della Rossa, A. J. Silman, C. M. Black, L. Czirják, H. Nielsen, P. G. Vlachoyiannopoulos

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Objective: To further assess the construct validity of the three European Scleroderma Study Group (EScSG) preliminary activity indices for systemic sclerosis (SSc): for SSc as a whole, for diffuse SSc (dcSSc), and for limited SSc (IcSSc). Methods: 30/290 SSc clinical charts collected for the EScSG study used to develop activity criteria for SSc were selected and sent to four clinical experts in SSc. The experts ranked the charts from 1 to 30 (1=lowest activity, 30=highest activity). The relationships among the ranks given by each investigator and each of the three scores, and between any two of the ranks were investigated. Results: A consistently significant correlation (r s=0.530-0.712) was found between the ranks given by each of the four investigators and the index for the entire patient group. A similar level of agreement was detected between each couple of the four experts (r s=0.428-0.720). Moreover, the ranks given in patients with an index >3 were significantly higher than those given for patients with an index ≤3. This cut off point had previously been shown to best discriminate patients with active disease. Conclusions: Of the originally developed activity indexes, the whole series index has been externally validated. The index comprises the first preliminary, but necessary, groundwork to improve the concept of disease activity in SSc, which is still ill defined. It can be used as a preliminary activity index in clinical investigational studies.

Original languageEnglish
Pages (from-to)901-903
Number of pages3
JournalAnnals of the Rheumatic Diseases
Volume62
Issue number9
DOIs
Publication statusPublished - Sep 1 2003

Fingerprint

Systemic Scleroderma
Research Personnel
Diffuse Scleroderma

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. / Valentini, G.; Bencivelli, W.; Bombardieri, S.; D'Angelo, S.; Della Rossa, A.; Silman, A. J.; Black, C. M.; Czirják, L.; Nielsen, H.; Vlachoyiannopoulos, P. G.

In: Annals of the Rheumatic Diseases, Vol. 62, No. 9, 01.09.2003, p. 901-903.

Research output: Contribution to journalArticle

Valentini, G, Bencivelli, W, Bombardieri, S, D'Angelo, S, Della Rossa, A, Silman, AJ, Black, CM, Czirják, L, Nielsen, H & Vlachoyiannopoulos, PG 2003, 'European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria', Annals of the Rheumatic Diseases, vol. 62, no. 9, pp. 901-903. https://doi.org/10.1136/ard.62.9.901
Valentini, G. ; Bencivelli, W. ; Bombardieri, S. ; D'Angelo, S. ; Della Rossa, A. ; Silman, A. J. ; Black, C. M. ; Czirják, L. ; Nielsen, H. ; Vlachoyiannopoulos, P. G. / European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. In: Annals of the Rheumatic Diseases. 2003 ; Vol. 62, No. 9. pp. 901-903.
@article{40ac0c78b36a489d94c1d7c1b98de0a4,
title = "European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria",
abstract = "Objective: To further assess the construct validity of the three European Scleroderma Study Group (EScSG) preliminary activity indices for systemic sclerosis (SSc): for SSc as a whole, for diffuse SSc (dcSSc), and for limited SSc (IcSSc). Methods: 30/290 SSc clinical charts collected for the EScSG study used to develop activity criteria for SSc were selected and sent to four clinical experts in SSc. The experts ranked the charts from 1 to 30 (1=lowest activity, 30=highest activity). The relationships among the ranks given by each investigator and each of the three scores, and between any two of the ranks were investigated. Results: A consistently significant correlation (r s=0.530-0.712) was found between the ranks given by each of the four investigators and the index for the entire patient group. A similar level of agreement was detected between each couple of the four experts (r s=0.428-0.720). Moreover, the ranks given in patients with an index >3 were significantly higher than those given for patients with an index ≤3. This cut off point had previously been shown to best discriminate patients with active disease. Conclusions: Of the originally developed activity indexes, the whole series index has been externally validated. The index comprises the first preliminary, but necessary, groundwork to improve the concept of disease activity in SSc, which is still ill defined. It can be used as a preliminary activity index in clinical investigational studies.",
author = "G. Valentini and W. Bencivelli and S. Bombardieri and S. D'Angelo and {Della Rossa}, A. and Silman, {A. J.} and Black, {C. M.} and L. Czirj{\'a}k and H. Nielsen and Vlachoyiannopoulos, {P. G.}",
year = "2003",
month = "9",
day = "1",
doi = "10.1136/ard.62.9.901",
language = "English",
volume = "62",
pages = "901--903",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "9",

}

TY - JOUR

T1 - European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria

AU - Valentini, G.

AU - Bencivelli, W.

AU - Bombardieri, S.

AU - D'Angelo, S.

AU - Della Rossa, A.

AU - Silman, A. J.

AU - Black, C. M.

AU - Czirják, L.

AU - Nielsen, H.

AU - Vlachoyiannopoulos, P. G.

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Objective: To further assess the construct validity of the three European Scleroderma Study Group (EScSG) preliminary activity indices for systemic sclerosis (SSc): for SSc as a whole, for diffuse SSc (dcSSc), and for limited SSc (IcSSc). Methods: 30/290 SSc clinical charts collected for the EScSG study used to develop activity criteria for SSc were selected and sent to four clinical experts in SSc. The experts ranked the charts from 1 to 30 (1=lowest activity, 30=highest activity). The relationships among the ranks given by each investigator and each of the three scores, and between any two of the ranks were investigated. Results: A consistently significant correlation (r s=0.530-0.712) was found between the ranks given by each of the four investigators and the index for the entire patient group. A similar level of agreement was detected between each couple of the four experts (r s=0.428-0.720). Moreover, the ranks given in patients with an index >3 were significantly higher than those given for patients with an index ≤3. This cut off point had previously been shown to best discriminate patients with active disease. Conclusions: Of the originally developed activity indexes, the whole series index has been externally validated. The index comprises the first preliminary, but necessary, groundwork to improve the concept of disease activity in SSc, which is still ill defined. It can be used as a preliminary activity index in clinical investigational studies.

AB - Objective: To further assess the construct validity of the three European Scleroderma Study Group (EScSG) preliminary activity indices for systemic sclerosis (SSc): for SSc as a whole, for diffuse SSc (dcSSc), and for limited SSc (IcSSc). Methods: 30/290 SSc clinical charts collected for the EScSG study used to develop activity criteria for SSc were selected and sent to four clinical experts in SSc. The experts ranked the charts from 1 to 30 (1=lowest activity, 30=highest activity). The relationships among the ranks given by each investigator and each of the three scores, and between any two of the ranks were investigated. Results: A consistently significant correlation (r s=0.530-0.712) was found between the ranks given by each of the four investigators and the index for the entire patient group. A similar level of agreement was detected between each couple of the four experts (r s=0.428-0.720). Moreover, the ranks given in patients with an index >3 were significantly higher than those given for patients with an index ≤3. This cut off point had previously been shown to best discriminate patients with active disease. Conclusions: Of the originally developed activity indexes, the whole series index has been externally validated. The index comprises the first preliminary, but necessary, groundwork to improve the concept of disease activity in SSc, which is still ill defined. It can be used as a preliminary activity index in clinical investigational studies.

UR - http://www.scopus.com/inward/record.url?scp=0042508746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042508746&partnerID=8YFLogxK

U2 - 10.1136/ard.62.9.901

DO - 10.1136/ard.62.9.901

M3 - Article

C2 - 12922968

AN - SCOPUS:0042508746

VL - 62

SP - 901

EP - 903

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 9

ER -